Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity
AFAR experts Joan Mannick, MD provides the latest information on promising geroprotectors in the wake of the corona virus pandemic.
https://www.afar.org/
Follow AFAR on Twitter and Facebook at @AFARorg
Видео Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity канала AFAR
https://www.afar.org/
Follow AFAR on Twitter and Facebook at @AFARorg
Видео Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity канала AFAR
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Webinar | Nir Barzilai, MD | How Geroscience Can Impact COVID-19
John Rowe, MD, Columbia University, on the importance of the Longevity Dividend Initiative
Webinar | Mechanisms of Behavior Change for Healthy Aging
Donald Edmondson: The Science of Behavior Change (SOBC) Program
Metabesity 2017: Qualifying Clinical Candidates for Anti Aging Interventions
Why is research on the basic biology of aging important for cardiovascular disease?
"AFAR is our lab's mitochondria" - 2016 AFAR Grantee, Changhan David Lee's testimonial
Neil Krause: Gender Differences and Stress Resilience
American Federation for Aging Research: MacArthur Foundation 100&Change Proposal
Dr. Judith Salerno women & science talk
Webinar | Incorporating Genetic Diversity in Mouse Models
Dog Aging Project Webinar
AFAR "Live Longer, Live Well" animation
Grantee Jenna Bartley on AFAR’s impact
Webinar | Summary Audience Questions on COVID-19 and Geroprotectors
James L. Kirkland, PhD, Mayo Clinic on how aging research will benefit us all
Felipe Sierra, PhD, National Institute on Aging, on the impact of aging research
Art Arnold: Animal Models for Studying Sex Differences
AFAR Board Member S. Jay Olshansky, PhD, on Geroscience
2009 AFAR Aging Heart Conference: Dr. Roger Hajjar